RE-BVS – Piemonte Repository

Sfoglia per AUTORE
DELL'ORCO S
Collezione ASL Vercelli

Items : 9

HSD64 Drug Discontinuation and Healthcare Cost Evaluation in Crohn's Disease Patients Under Biologic Therapy: An Italian Retrospective Analysis in Value in Health

2022
ASL Vercelli

Perrone V; Secchi O; Serra A; Franchi A; Dovizio M; Sangiorgi D; Andretta M; Antonacci S; Barbieri A; Bartolini F; Cavaliere A; Ciaccia A; Cillo MR; Citraro R; Costantini A; Dell'Orco S; Grego S; Moscogiuri R; Mosele E; Procacci C; Santoleri F; Vercellone A; Degli Esposti L;

Clinical Profile and Healthcare Resource Use of ANCA-Associated Vasculitis: A Real-World Analysis in Italy in Value in Health

2022
ASL Vercelli

Perrone V; Dovizio M; Veronesi C; Andretta M; Bacca M; Barbieri A; Bartolini F; Cavaliere A; Chinellato A; Ciaccia A; Cillo MR; Citraro R; Costantini A; Dell'Orco S; Ferrante F; Gentile S; Grego S; Lavalle A; Mancini D; Moscogiuri R; Mosele E; Pagliaro R; Procacci C; Re D; Santoleri F; Ubertazzo L; Vercellone A; Ramirez de Arellano Serna A; Degli Esposti L; et alii...

HSD61 Trends in Discontinuation of Lipid-Lowering and Antihypertensive Therapies: A Real-World Data Analysis in Italy in Value in Health

2022
ASL Vercelli

Dovizio M; Perrone V; Iacolare B; Andretta M; Bacca M; Barbieri A; Bartolini F; Cavaliere A; Chinellato A; Ciaccia A; Cillo MR; Costantini A; Dell'Orco S; Ferrante F; Gentile S; Grego S; Lavalle A; Maccio S; Mancini D; Moscogiuri R; Mosele E; Pagliaro R; Pastorello M; Procacci C; Re D; Santoleri F; Ubertazzo L; Vercellone A; Degli Esposti L; et alii...

HSD16 PCSK-9 Inhibitors for the Control of Hypercholesterolemia: Eligibility for Treatment, Prescription Appropriateness and Outcomes, in a Real-World Clinical Setting in Value in Health

2022
ASL Vercelli

Perrone V; Iacolare B; Dovizio M; Andretta M; Bacca M; Barbieri A; Bartolini F; Cavaliere A; Chinellato A; Ciaccia A; Cillo MR; Costantini A; Dell'Orco S; Ferrante F; Gentile S; Grego S; Lavalle A; Maccio S; Mancini D; Moscogiuri R; Mosele E; Pagliaro R; Pastorello M; Procacci C; Re D; Santoleri F; Ubertazzo L; Vercellone A; Degli Esposti L; et alii...

POSA310 Artificial Intelligence Applied on Administrative Big Data to Predict the Severity of SARS-COV-2 Infection in Value in Health

2022
ASL Vercelli

Iacolare B; Perrone V; Sangiorgi D; Ghigi A; Giacomini E; Nappi C; Paoli D; Ancona DD; Andretta M; Barbieri A; Bartolini F; Cavaliere A; Ciaccia A; Citraro R; Dell'Orco S; Ferrante F; Gentile S; Grego S; Procacci C; Ubertazzo L; Vercellone A; Degli Esposti L;

POSB240 The Effects of COVID-19 Infection on Medication Adherence with Chronic Therapies in Italy: The Fail-to-Refill Project in Value in Health

2022
ASL Vercelli

Degli EL; Ghigi A; Ancona DD; Andretta M; Barbieri A; Bartolini F; Cavaliere A; Ciaccia A; Dell'Orco S; Di MG; Grego S; Latini M; Luboz J; Nava E; Paciello A; Pagliaro R; Penna A; Salzano S; Tonello I; Ubertazzo L; Vercellone A; Perrone V;

Use of Real-World Big Data to Assess the Effectiveness on Overall Survival Among Chemotherapy or Immunotherapy in First Line Metastatic Non-Small Cell Lung Carcinoma Patients in an Italian Setting in Value in Health

2022
ASL Vercelli

Degli Esposti L; Sangiorgi D; Ancona DD; Andretta M; Barbieri A; Bartolini F; Cavaliere A; Chinellato A; Ciaccia A; Cillo MR; Citraro R; Costantini A; De Francesco A; Dell'Orco S; Di Manno G; Ferrante F; Gentile S; Lavalle A; Moscogiuri R; Pastorello M; Procacci C; Re D; Santoleri F; Ubertazzo L; Vercellone A; Perrone V;

POSC156 Clinical Burden, Treatment Pathway, and Healthcare Resource Utilization of Transfusion-Dependent Beta-Thalassemia Patients in Italy: A Retrospective Analysis in Value in Health

2022
ASL Vercelli

Perrone V; Veronesi C; Giacomini E; Ancona DD; Andretta M; Barbieri A; Bartolini F; Bianco D; Cavaliere A; Chinellato A; Ciaccia A; Cillo MR; Citraro R; Dell'Orco S; Ferrante F; Gentile S; Serao Creazzola S; Pastorello M; Procacci C; Re D; Tegon M; Ubertazzo L; Vercellone A; Degli Esposti L;

Cardiovascular Events and Mortality in Type-2 Diabetic Patients under Second-Line Treatment with Hypoglycemic Agents: An Italian Real-World Study in Value in Health

2022
ASL Vercelli

Degli EL; Sangiorgi D; Nappi C; Andretta M; Barbieri A; Citraro R; Bartolini F; Cavaliere A; Ciaccia A; Chinellato A; Cillo MR; Dell'Orco S; Ferrante F; Gentile S; Procacci C; Re D; Ubertazzo L; Vercellone A; Perrone V;